MedCap AB (publ)

MedCap AB (publ) EBIT Margin

The EBIT Margin (Operating Margin) of MedCap AB (publ) (MCAP.ST) as of Oct 11, 2026 is 14.24 %. In the previous year, EBIT Margin (Operating Margin) was 15.07 % — a change of -5.51% (lower).

EBIT Margin

14.24 %

YoY

-5.51%

Last updated:

EBIT Margin (Operating Margin) of MedCap AB (publ) is 2025 14.24 % . EBIT Margin (Operating Margin) of MedCap AB (publ) was 2024 15.07 % . It decreases by -5.51% lower compared to the previous year.

For MedCap AB (publ), the operating (EBIT) margin of 14.2% is broadly stable versus 13.9% a few years ago.

The MedCap AB (publ) EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
6.74 SEK
Jan 1, 2019
10.99 SEK
Jan 1, 2020
10.90 SEK
Jan 1, 2021
13.86 SEK
Jan 1, 2022
15.38 SEK
Jan 1, 2023
14.33 SEK
Jan 1, 2024
15.07 SEK
Jan 1, 2025
14.24 SEK
The MedCap AB (publ) EBIT Margin history
YEAREBIT MarginYoY
14.24 %-5.51%
15.07 %+5.16%
14.33 %-6.80%
15.38 %+10.94%
13.86 %+27.15%
10.90 %-0.81%
10.99 %+63.00%
6.74 %+52.49%
4.42 %-1,044.89%
-0.47 %-111.89%
3.94 %+206.81%
1.28 %+3,331.07%
0.04 %-36.30%
0.06 %+5.89%
0.06 %-33.42%
0.08 %+71.54%
0.05 %-3,688.36%
-0.00-93.33%
-0.02 %+500.96%
-0.00—
Access this data via the Eulerpool API

MedCap AB (publ) Stock analysis

What does MedCap AB (publ) do? MedCap AB (publ) is a Swedish company specializing in the development and marketing of medical products. The company was founded in 2006 by a group of experts in the medical industry. MedCap's business model is focused on developing and marketing innovative medical products. The company has two main business areas: Medical Devices and Diagnostics. In the Medical Devices area, MedCap develops products for various medical applications, including respiratory diseases, pain therapy, and wound care. In the Diagnostics area, the company offers diagnostic tests for various diseases, including infectious diseases and cancer. MedCap aims to improve medical care through innovative products. The company has introduced a range of groundbreaking products that offer higher effectiveness and more convenient use for patients. An example of a MedCap product is the Aeroneb® Pro. This is an advanced nebulizer device used for the treatment of respiratory diseases such as asthma, COPD, and cystic fibrosis. According to MedCap, the Aeroneb® Pro is the most effective nebulizer device of its kind, offering higher medication absorption through the lungs than other nebulizer devices. Another MedCap product is the ClipOn® Pain Relief. This is a portable pain reliever used to alleviate pain from various diseases such as arthritis and back pain. According to MedCap, the ClipOn® Pain Relief is a fast and safe way to relieve pain and improve patients' quality of life. In the Diagnostics area, MedCap offers a range of diagnostic tests for infectious diseases, including HIV, hepatitis, and tuberculosis. An example of a MedCap diagnostic test is the Diagnostics Quick Test (DQT), a rapid test for HIV detection. According to MedCap, the DQT is the fastest HIV test on the market, providing results in just 15 minutes. MedCap has also focused on the field of personalized medicine. The company has developed a platform called Confero that enables doctors to offer personalized medicine to their patients. Confero utilizes artificial intelligence and machine learning to provide accurate diagnosis and treatment for each patient. Overall, MedCap has established itself as a leading company in the medical industry, offering innovative products and services for medical care. The company has a strong presence in Europe and is also expanding into other parts of the world. MedCap aims to improve medical care through its products and services, making a positive impact on the lives of patients. MedCap AB (publ) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedCap AB (publ) stock

EBIT Margin (Operating Margin) of MedCap AB (publ) is 14.24 % in 2025.

EBIT Margin (Operating Margin) of MedCap AB (publ) changed from 15.07 % to 14.24 %, representing a -5.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) MedCap AB (publ) since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s MedCap AB (publ) with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — MedCap AB (publ)

All Key Metrics — MedCap AB (publ)